We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.

This study has been terminated.
(Diakron Pharmaceuticals couldn't fulfill the financial responsibility of the study)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01647620
First Posted: July 23, 2012
Last Update Posted: February 24, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Drug Research Unit Ghent, Ghent, Belgium
Kinesis Pharma BV, Breda, the Netherlands
Information provided by (Responsible Party):
Diakron Pharmaceuticals
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)